Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study.


Journal

The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019

Informations de publication

Date de publication:
04 2021
Historique:
received: 01 04 2020
revised: 07 12 2020
accepted: 15 01 2021
entrez: 11 5 2022
pubmed: 12 5 2022
medline: 18 5 2022
Statut: ppublish

Résumé

The epidemiology and severity of non-falciparum malaria in endemic settings has garnered little attention. We aimed to characterise the prevalence, interaction, clinical risk factors, and temporal trends of non-falciparum Plasmodium species among symptomatic individuals presenting at health-care facilities in endemic settings of Kenya. We diagnosed and analysed infecting malaria species (Plasmodium falciparum, Plasmodium ovale curtisi, Plasmodium ovale wallikeri, and Plasmodium malariae) via PCR in clinical samples collected between March 1, 2008, and Dec 31, 2016, from six hospitals located in different regions of Kenya. We recruited patients aged 6 months or older who presented at outpatient departments with symptoms of malaria or tested positive for uncomplicated malaria by malaria rapid diagnostic test. Descriptive statistics were used to describe the prevalence and distribution of Plasmodium species. A statistical model was designed and used for estimating the frequency of Plasmodium species and assessing interspecies interactions. Mixed-effect linear regression models with random slopes for each location were used to test for change in prevalence over time. Samples from 2027 symptomatic participants presenting at care facilities were successfully analysed for all Plasmodium species. 1469 (72·5%) of the samples were P falciparum single-species infections, 523 (25·8%) were mixed infections, and only 35 (1·7%) were single non-falciparum species infections. 452 (22·3%) were mixed infections containing P ovale spp. A likelihood-based model calculation of the population frequency of each species estimated a significant within-host interference between P falciparum and P ovale curtisi. Mixed-effect logistic regression models identified a significant increase in P ovale wallikeri (2·1% per year; p=0·043) and P ovale curtisi (0·7% per year; p=0·0002) species over time, with a reciprocal decrease in P falciparum single-species infections (2·5% per year; p=0·0065). The frequency of P malariae infections did not significantly change over time. Risk of P falciparum infections presenting with fever was lower if co-infected with P malariae (adjusted odds ratio 0·43, 95% CI 0·25-0·74; p=0·0023). Our results show a prevalence of non-falciparum species infections of 27·5% among symptomatic individuals presenting at care facilities, which is higher than expected from previous cross-sectional surveys. The proportion of infections with P ovale wallikeri and P ovale curtisi was observed to significantly increase over the period of study, which could be due to attenuated responsiveness of these species to malaria drug treatment. The increase in frequency of P ovale spp could threaten the malaria control efforts in Kenya and pose increased risk of malaria to travellers. Armed Forces Health Surveillance Branch and its Global Emerging Infections Surveillance Section.

Sections du résumé

BACKGROUND
The epidemiology and severity of non-falciparum malaria in endemic settings has garnered little attention. We aimed to characterise the prevalence, interaction, clinical risk factors, and temporal trends of non-falciparum Plasmodium species among symptomatic individuals presenting at health-care facilities in endemic settings of Kenya.
METHODS
We diagnosed and analysed infecting malaria species (Plasmodium falciparum, Plasmodium ovale curtisi, Plasmodium ovale wallikeri, and Plasmodium malariae) via PCR in clinical samples collected between March 1, 2008, and Dec 31, 2016, from six hospitals located in different regions of Kenya. We recruited patients aged 6 months or older who presented at outpatient departments with symptoms of malaria or tested positive for uncomplicated malaria by malaria rapid diagnostic test. Descriptive statistics were used to describe the prevalence and distribution of Plasmodium species. A statistical model was designed and used for estimating the frequency of Plasmodium species and assessing interspecies interactions. Mixed-effect linear regression models with random slopes for each location were used to test for change in prevalence over time.
FINDINGS
Samples from 2027 symptomatic participants presenting at care facilities were successfully analysed for all Plasmodium species. 1469 (72·5%) of the samples were P falciparum single-species infections, 523 (25·8%) were mixed infections, and only 35 (1·7%) were single non-falciparum species infections. 452 (22·3%) were mixed infections containing P ovale spp. A likelihood-based model calculation of the population frequency of each species estimated a significant within-host interference between P falciparum and P ovale curtisi. Mixed-effect logistic regression models identified a significant increase in P ovale wallikeri (2·1% per year; p=0·043) and P ovale curtisi (0·7% per year; p=0·0002) species over time, with a reciprocal decrease in P falciparum single-species infections (2·5% per year; p=0·0065). The frequency of P malariae infections did not significantly change over time. Risk of P falciparum infections presenting with fever was lower if co-infected with P malariae (adjusted odds ratio 0·43, 95% CI 0·25-0·74; p=0·0023).
INTERPRETATION
Our results show a prevalence of non-falciparum species infections of 27·5% among symptomatic individuals presenting at care facilities, which is higher than expected from previous cross-sectional surveys. The proportion of infections with P ovale wallikeri and P ovale curtisi was observed to significantly increase over the period of study, which could be due to attenuated responsiveness of these species to malaria drug treatment. The increase in frequency of P ovale spp could threaten the malaria control efforts in Kenya and pose increased risk of malaria to travellers.
FUNDING
Armed Forces Health Surveillance Branch and its Global Emerging Infections Surveillance Section.

Identifiants

pubmed: 35544189
pii: S2666-5247(21)00009-4
doi: 10.1016/S2666-5247(21)00009-4
pmc: PMC7613221
mid: EMS147026
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e141-e150

Subventions

Organisme : Wellcome Trust
ID : 109312
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

Front Immunol. 2020 Jan 22;10:3072
pubmed: 32038623
Malar J. 2018 Oct 5;17(1):352
pubmed: 30290815
PLoS One. 2014 Feb 10;9(2):e87169
pubmed: 24520325
Clin Infect Dis. 2019 Nov 27;69(12):2119-2126
pubmed: 31066448
Malar J. 2014 Sep 03;13:351
pubmed: 25187326
Lancet. 1994 Apr 30;343(8905):1095
pubmed: 7909108
Ecol Lett. 2016 Sep;19(9):1041-50
pubmed: 27364562
Malar J. 2014 Jun 18;13:240
pubmed: 24946685
BMC Med. 2018 Nov 27;16(1):218
pubmed: 30477484
Trends Parasitol. 2004 Sep;20(9):440-7
pubmed: 15324735
Parasitol Res. 2016 Jun;115(6):2139-48
pubmed: 27079460
PLoS Negl Trop Dis. 2019 May 28;13(5):e0007414
pubmed: 31136585
PLoS One. 2012;7(10):e48033
pubmed: 23110165
Clin Microbiol Rev. 2008 Jan;21(1):97-110
pubmed: 18202438
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2):6-8
pubmed: 11425165
J Infect Dis. 2018 Mar 13;217(7):1099-1109
pubmed: 29325068
Sci Rep. 2016 Nov 14;6:36958
pubmed: 27841361
Malar J. 2017 Aug 15;16(1):339
pubmed: 28810865
BMJ Open. 2013 May 28;3(5):
pubmed: 23793668
Curr Opin Microbiol. 2002 Aug;5(4):431-7
pubmed: 12160865
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):119-27
pubmed: 18165483
J Clin Microbiol. 2011 Aug;49(8):2946-53
pubmed: 21653767
J Infect Dis. 2019 Sep 13;220(8):1335-1345
pubmed: 31175365
Malar J. 2013 Feb 19;12:67
pubmed: 23421809
New Microbiol. 2003 Jan;26(1):91-100
pubmed: 12578316
Int J Parasitol Drugs Drug Resist. 2013 Jan 19;3:45-50
pubmed: 24533292
Int J Parasitol. 2011 May;41(6):677-83
pubmed: 21315074
Parasitology. 2014 Dec;141(14):1880-90
pubmed: 24837880

Auteurs

Hoseah M Akala (HM)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya. Electronic address: hosea.akala@usamru-k.org.

Oliver J Watson (OJ)

Medical Research Council, Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.

Kenneth K Mitei (KK)

College of Health Sciences, Makerere University, Kampala, Uganda.

Dennis W Juma (DW)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Robert Verity (R)

Medical Research Council, Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.

Luicer A Ingasia (LA)

Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Benjamin H Opot (BH)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Raphael O Okoth (RO)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Gladys C Chemwor (GC)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Jackline A Juma (JA)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Edwin W Mwakio (EW)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Nicholas Brazeau (N)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.

Agnes C Cheruiyot (AC)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Redemptah A Yeda (RA)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Maureen N Maraka (MN)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Charles O Okello (CO)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

David P Kateete (DP)

College of Health Sciences, Makerere University, Kampala, Uganda.

Jim Ray Managbanag (JR)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Ben Andagalu (B)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Bernhards R Ogutu (BR)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya.

Edwin Kamau (E)

Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH